Last updated 20 months ago

Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -

110 patients around the world
Available in Brazil
Hospital Israelita Albert Einstein
1Research sites
110Patients around the world
This study is for people with
Migraine
Requirements for the patient
To 65 Years
All Gender
Medical requirements
Sites
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
Recruiting
Bloco A1 - Av. Albert Einstein, 627 - Jardim Leonor, São Paulo - SP, 05652-900, Brazil
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy